Vision training shows promise for macular degeneration patients
NCT ID NCT05454124
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether special vision training can improve how people with central vision loss from macular degeneration see and move their eyes. Researchers will train 60 adults aged 18 to 89 with severe vision loss to better detect and discriminate visual patterns. The goal is to understand how the brain adapts after vision loss, which could lead to new low-vision therapies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- vision training (behavioral intervention)
- What this could lead to
- If successful, this could point toward new therapies to improve vision and daily function for people with low vision from macular degeneration.
- What could go wrong
- This is an early-stage, observational study with only 60 participants. It is not testing a treatment or cure, and results may not lead to a practical therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL VISUAL IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UAB
RECRUITINGBirmingham, Alabama, 35294, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blindness may boost your sense of taste and smell, scientists say
- Could stem cells restore sight in damaged eyes?
- Tiny genetic clues may unlock eye disease mysteries
- New eye training aims to help millions with macular degeneration see again
- Eye drops could replace needles for wet AMD?
- New eye scanner software could sharpen diagnosis of macular degeneration